1. Home
  2. PAYS vs ARDX Comparison

PAYS vs ARDX Comparison

Compare PAYS & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysign Inc.

PAYS

Paysign Inc.

N/A

Current Price

$9.40

Market Cap

780.3M

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.11

Market Cap

724.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAYS
ARDX
Founded
2001
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.3M
724.0M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
PAYS
ARDX
Price
$9.40
$3.11
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $14.81
$12.50
AVG Volume (30 Days)
1.2M
★ 4.6M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 85.71
N/A
EPS
★ 0.30
N/A
Revenue
★ $24,120,434.00
$2,607,000.00
Revenue This Year
$40.90
$18.39
Revenue Next Year
$12.70
$26.08
P/E Ratio
$31.48
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.08
$2.80
52 Week High
$16.15
$8.40

Technical Indicators

Market Signals
Indicator
PAYS
ARDX
Relative Strength Index (RSI) 26.49 48.00
Support Level $8.26 $2.96
Resistance Level $14.06 $3.38
Average True Range (ATR) 1.17 0.16
MACD -0.68 0.03
Stochastic Oscillator 3.13 49.18

Price Performance

Historical Comparison
PAYS
ARDX

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: